Curaleaf Holdings (CURLF) Shares Outstanding (Diluted Average) (2020 - 2025)

Curaleaf Holdings (CURLF) recorded quarterly Shares Outstanding (Diluted Average) of $762.1 million in Q4 2025, up 2.87% quarter-over-quarter from $740.8 million in Q4 2024, and up 2.87% on a YoY basis from $740.8 million in Q4 2024.

Curaleaf Holdings (CURLF) Shares Outstanding (Diluted Average) (2020 - 2025) Analysis & Trends

Curaleaf Holdings' Shares Outstanding (Diluted Average) history runs 4 years deep, the most recent figure standing at $762.1 million for Q4 2025.

  • In Q4 2025, Shares Outstanding (Diluted Average) rose 2.87% year-over-year to $762.1 million; the TTM figure through Dec 2025 stood at $762.1 million (up 2.87% YoY), while the FY2025 annual figure was $762.1 million, up 2.87% from the prior year.
  • Shares Outstanding (Diluted Average) was $762.1 million for Q4 2025 at Curaleaf Holdings, up from $740.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $762.1 million in Q4 2025 to a low of $724.1 million in Q4 2023.
  • Historically, Shares Outstanding (Diluted Average) has averaged $742.3 million across 3 years, with a median of $740.8 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) climbed 2.31% in 2024, then rose 2.87% in 2025.
  • A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $724.1 million in 2023, then increased by 2.31% to $740.8 million in 2024, then gained by 2.87% to $762.1 million in 2025.
  • The last three Shares Outstanding (Diluted Average) figures came in at $762.1 million (Q4 2025), $740.8 million (Q4 2024), and $724.1 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.18 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 47.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 103.40 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 Curaleaf Holdings - - 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 762.09 Mn
Dec 31, 2024 740.83 Mn
Dec 31, 2023 724.12 Mn
Dec 31, 2020 557.19 Mn